scPharmaceuticals Inc. SCPH
Set alert
5.67 0.00 0.00%
At close · Oct 7
5.67 Day range 5.67
52-week range unavailable
- YTD
- +60.17%
- 1 year
- +32.48%
- Open
- 5.67
- Prev close
- 5.67
- Mkt cap
- 302.20M
- Vol
- 10.90M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.67
- High
- 5.67
- Forward P/E
- -4.68
- Beta
- 0.00
- Short ratio
- 11.41
- Inst. own
- 81.64%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 3.82
- 200-d avg
- 4.45
- 1y target
- 17.50
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 17.50 +208.6% upside
Now 5.67
- Target (low)
- 12.00
- Target (mean)
- 17.50
- Target (high)
- 25.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy2
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.38667 | -0.46 – -0.32 | -0.35 | -10.5% | 12.18M | +99.7% | 3 |
| Next quarter | -0.28667 | -0.38 – -0.17 | -0.36 | +20.4% | 14.43M | +136.5% | 3 |
| Current year | -1.78 | -2.02 – -1.49 | -1.42 | -25.6% | 36.33M | +167.3% | 3 |
| Next year | -1.08 | -1.30 – -0.95 | -1.78 | +39.4% | 84.09M | +131.4% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | Craig-Hallum | Maintained | Buy | Buy |
| Aug 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 7, 2023 | Craig-Hallum | Initiated | — | Buy |
| Aug 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 2, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 19, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 8, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 11, 2023 | Maxim Group | Maintained | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 23, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jan 27, 2023 | SVB Leerink | Maintained | — | Outperform |
| Dec 1, 2022 | Cowen & Co. | Initiated | — | Outperform |
| Nov 10, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 10, 2022 | SVB Leerink | Maintained | — | Outperform |
| Oct 11, 2022 | SVB Leerink | Upgrade | Market Perform | Outperform |
| Aug 2, 2022 | Maxim Group | Initiated | — | Buy |
| May 17, 2022 | SVB Leerink | Maintained | — | Market Perform |
| Sep 9, 2021 | SVB Leerink | Initiated | — | Market Perform |
| Nov 30, 2020 | SVB Leerink | Maintained | — | Market Perform |
| May 27, 2020 | SVB Leerink | Maintained | — | Market Perform |
| May 13, 2020 | HC Wainwright & Co. | Reiterated | — | Buy |
| Oct 15, 2019 | HC Wainwright & Co. | Initiated | — | Buy |
| Jan 30, 2019 | Leerink Swann | Downgrade | Outperform | Market Perform |
| Jun 14, 2018 | Jefferies | Maintained | Buy | Buy |
| Jun 14, 2018 | BMO Capital | Maintained | Outperform | Outperform |
| Dec 12, 2017 | BMO Capital | Initiated | — | Outperform |
| Dec 12, 2017 | Jefferies | Initiated | — | Buy |